Sakar Healthcare enterprise value

·UnclassifiedChart ›

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,964	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.0	50.1	0.1	0.3	3.5
55.3	55.3	75.0	68.8	111
2,019	—	—	—	—
55.3	5.2	74.9	68.6	108
₹907.63	—	—	—	—

401	380	360	331	285
13.8%	14.6%	20.8%	20.8%	39.1%
0.03×	—	—	—	—

6.69×	—	—	—	—
22.33×	—	—	—	—
31.08×	—	—	—	—
41.00×	—	—	—	—
302	252	178	153	133
90.4	68.9	49.7	38.4	33.1
65.0	45.3	28.8	20.3	18.2
—	49.3	35.6	24.5	33.3
49.3	49.3	3.3	−35.1	−48.9
—	47.6	1.9	−36.9	−50.2
—	0.0	32.3	59.6	82.2

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAKAR₹882.80

Sakar Healthcare Limited

· Unclassified

₹ CrorePeersMACPOWER SERVOTECH KAPSTON THEJOBETAMcap ₹1,964 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,964.2
- Cash, Equiv & ST Investments	3.5	0.3	0.1	50.1	0.0
+ Total Debt	111.2	68.8	75.0	55.3	55.3
Enterprise Value	—	—	—	—	2,019.5
Net Debt (memo)	107.7	68.6	74.9	5.2	55.3
EV per Share	—	—	—	—	907.63

Total Capital	284.6	331.2	360.4	379.8	401.3
Total Debt/Total Capital	39.09	20.79	20.80	14.56	13.78
Total Debt/EV	—	—	—	—	0.03

EV/Sales	—	—	—	—	6.69
EV/EBITDA	—	—	—	—	22.33
EV/EBIT	—	—	—	—	31.08
EV/Free Cash Flow	—	—	—	—	41.00
Reference Items — Trailing FY Values
Sales	133.4	153.4	177.6	251.7	301.8
EBITDA	33.1	38.4	49.7	68.9	90.4
EBIT	18.2	20.3	28.8	45.3	65.0
Operating Cash Flow	33.3	24.5	35.6	49.3	—
Free Cash Flow	-48.9	-35.1	3.3	49.3	49.3
FCFF (free cash flow to the firm)	-50.2	-36.9	1.9	47.6	—
Capital Expenditure	82.2	59.6	32.3	0.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.